Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Otolaryngology (Ear, Nose, Throat) | Pulmonary/Respiratory Diseases | Immunology | Infections and Infectious Diseases
Disease Category: Allergy
Location: United States, NY
Diagnosis of Aspirin Hypersensitivity by Measuring Arachidonic Acid Metabolites after Low Dose Aspirin Challenge
This is a research study of a new approach to diagnose aspirin allergy. Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) is frequently reported by patients requiring aspirin (ASA) for coronary artery disease or NSAIDs for pain management. Even though clinical challenge with relatively high doses of aspirin carries a substantial risk of severe reactions in ASA-hypersensitive population (e.g., bronchospasm), it is used as a gold standard to confirm the diagnosis of ASA hypersensitivity (AH) . A safer, more time and cost efficient test to diagnose ASA-hypersensitivity would be useful.
CW ID: 164960
Date Last Changed:
July 23, 2013
Elina Jerschow, MD, Principal InvestigatorThe Harold & Muriel Block Institute for Clinical and Translational Research at Einstein & MontefioreAlbert Einstein College of Medicine/Montefiore Medical Center
1515 Blondell Ave., Suite 220Bronx, NY 10461Phone: 866-MED-TALK
The Harold & Muriel Block Institute for Clinical and Translational Research at Einstein & Montefiore
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2017 CenterWatch.